Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Eisai Co. Ltd. (ESALY.PK)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ESALY.PK
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on ESALY.PK
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
How do explain the fact that US Pharma companies spend 2 - 3 times in BME (business development, advertising, marketing and lobbying)...
More »
Comment by
E Nuff Sed
Nov 2 23:03 pm
|
Rating:
+1
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
Listen Grandad. Pharma research is exactly like defense. In the past, the U.S. has defended the rest of the world because the other...
More »
Comment by
Steve in Greensboro
Nov 1 22:19 pm
|
Rating:
0
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
c smith: if you have that private pay data readily available for the other companies, that would be good data to share
Comment by
Richard Shaw
Nov 1 11:03 am
|
Rating:
0
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
c smith: nice point
Comment by
Richard Shaw
Nov 1 10:40 am
|
Rating:
0
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
A better measure of sensitivity to ObamaCare is percentage of revenue which is "private pay"; i.e.; that which is not publicly funded...
More »
Comment by
c smith
Oct 31 20:37 pm
|
Rating:
+1
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
Herbal or alternative or fringe etc. medications are not the issue. Hard science pharma (or a reasonable facsimile in view of the...
More »
Comment by
searcher
Oct 31 14:58 pm
|
Rating:
+1
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
I suspect the concern raised by the author is overblown. Other than adding more lives to be insured and saddling the taxpayer with more...
More »
Comment by
skwestorange
Oct 31 14:39 pm
|
Rating:
+1
-1
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
The FDA just sent a threatening letter to Dr. Weil for advocating use of an herbal preparation that many use and have reported benefit...
More »
Comment by
Jade Queen
Oct 31 12:18 pm
|
Rating:
0
-2
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
grandad: we aren't suggesting what ought to be, just the way it has been and the consequence of the way it would become -- there is no...
More »
Comment by
Richard Shaw
Oct 31 09:33 am
|
Rating:
+2
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
Are you serious ? Why the hell should U.S. citizens pay more for drugs so that foreign companies can have money to do research. I don
Comment by
grandad
Oct 31 09:19 am
|
Rating:
+1
-2
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
Thanks, Mr. Shaw, for the helpful note. "...the profitable private market in the U.S. has enabled much of the research and development...
More »
Comment by
Steve in Greensboro
Oct 30 09:03 am
|
Rating:
+2
0
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time
[View article]
EP: I posted this at my blog. http://seekingalpha.com/instablog/353266-justin-m-hall/33329-update-on-supergen-supg-by-ep-vantage
Comment by
Justin M. Hall
Oct 28 08:09 am
|
Rating:
+1
0
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time
[View article]
EP: Thank you for the article on SUPG. I like this company and view it as a decent early-stage play with plenty of cash. Justin
Comment by
Justin M. Hall
Oct 28 08:05 am
|
Rating:
+1
0
Small Cap Stocks Battling Brain Cancer
[View article]
I would be interested in receiving feedback from interested readers.
Comment by
Savitri Das
Sep 8 21:44 pm
|
Rating:
0
0
Small Cap Stocks Battling Brain Cancer
[View article]
I am surprised that Oncolytics Biotech candidate Reolysin was not mentioned here. For more info. read this recent article from the...
More »
Comment by
Savitri Das
Sep 8 21:43 pm
|
Rating:
0
0
1
2
Next Page
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time [View article]
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time [View article]
Small Cap Stocks Battling Brain Cancer [View article]
Small Cap Stocks Battling Brain Cancer [View article]